New trial tests stronger chemo to spare rectal cancer patients from surgery
Disease control
Not yet recruiting
This study aims to see if a more intensive three-drug chemotherapy regimen (FOLFOXIRI) works better than a standard two-drug regimen (CAPOX/FOLFOX) for patients with high-risk rectal cancer that hasn't spread. Both groups will also receive standard chemoradiation and may have sur…
Phase: PHASE3 • Sponsor: J. W. A. Burger • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC